Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines
Conclusions: These data illustrate the potential of MM-DX-929 PET as a companion diagnostic strategy to prospectively select patients likely to respond to liposomal drugs or nanomedicines of similar molecular size.
Source: Theranostics - Category: Molecular Biology Authors: Helen Lee, Daniel Gaddy, Manuela Ventura, Nicholas Bernards, Raquel de Souza, Dmitri Kirpotin, Thomas Wickham, Jonathan Fitzgerald, Jinzi Zheng, Bart S. Hendriks Tags: Research Paper Source Type: research